Callodine Equity Income Series GSK Holdings History
Callodine Equity Income Series's GSK PLC Holding Summary
As of 2025-03-31, Callodine Equity Income Series held 200,000.00 shares of GSK PLC(GSK), totaling $7.75 Mil. This investment constitutes 4.7% of their stock portfolio, and Callodine Equity Income Series now holds 0.01% of the outstanding GSK PLC(GSK) stock.
The initial trade took place in 2023Q4. And since then Callodine Equity Income Series has made 2 purchases of GSK, at an average price of $37.41, for a total of 205,000.00 shares. In addition, there have been 1 sales at an average price of $41.24 for 5,000.00 shares. Based on historical transaction data and GSK's current price of $38.55, Callodine Equity Income Series's estimated gain on his GSK holdings is $246,700.00, reflecting a 3.22% gain to date.
Callodine Equity Income Series GSK ($38.55) Holding Chart
Callodine Equity Income Series GSK ($38.55) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
